Skip to content
Quant500 - Quantitative Analysis
Search ticker or company...
ES | EN

Company Profile

When does Edwards Lifesciences Corporation (EW) report earnings? On Nov 4, 2026, after the close

None of its last 12 announcements carries a time on the filing, so there is no way to say which session they fell in. Each one comes from the 8-K with item 2.02 that Edwards Lifesciences filed with the SEC, paired with the 10-Q or 10-K for that same quarter: 65 quarters since Jul 21, 2010, and every row links to its filing.

Next announced date: Nov 4, 2026, after the close. It comes from the company through the public Nasdaq calendar, not from the SEC: it is a scheduled date and companies do move it. Everything else on this page already happened, with its filing attached.

Day of the weekThursday6 of 12
After the quarter ends24.5 daysmedian over the window
Lead over the 10-Q/10-K8.5 sessionsmedian over the window
Quarters on file65since Jul 21, 2010

The last 20 quarters, one by one

"Lead": trading sessions between the announcement and the full quarterly report to the SEC (10-Q, or 10-K at fiscal year end). For Edwards Lifesciences, a median of 8.5 sessions over the last 12 quarters.

AnnouncementDayTime (NY)SessionQuarter endedSEC reportLeadFiling
Jul 23, 2026Thursdayno time on the filingJun 30, 202610-Q · Aug 4, 20268 sessions8-K
Apr 23, 2026Thursdayno time on the filingMar 31, 202610-Q · May 6, 20269 sessions8-K
Feb 10, 2026Tuesdayno time on the filingDec 31, 202510-K · Feb 25, 202610 sessions8-K
Oct 30, 2025Thursdayno time on the filingSep 30, 202510-Q · Nov 5, 20254 sessions8-K
Jul 24, 2025Thursdayno time on the filingJun 30, 202510-Q · Aug 6, 20259 sessions8-K
Apr 23, 2025Wednesdayno time on the filingMar 31, 202510-Q · May 6, 20259 sessions8-K
Feb 11, 2025Tuesdayno time on the filingDec 31, 202410-K · Feb 28, 202512 sessions8-K
Oct 24, 2024Thursdayno time on the filingSep 30, 202410-Q · Nov 6, 20249 sessions8-K
Jul 24, 2024Wednesdayno time on the filingJun 30, 202410-Q · Jul 31, 20245 sessions8-K
Apr 25, 2024Thursdayno time on the filingMar 31, 202410-Q · Apr 29, 20242 sessions8-K
Feb 6, 2024Tuesdayno time on the filingDec 31, 202310-K · Feb 12, 20244 sessions8-K
Oct 25, 2023Wednesdayno time on the filingSep 30, 202310-Q · Oct 27, 20232 sessions8-K
Jul 26, 2023Wednesdayno time on the filingJun 30, 202310-Q · Jul 28, 20232 sessions8-K
Apr 26, 2023Wednesdayno time on the filingMar 31, 202310-Q · Apr 28, 20232 sessions8-K
Jan 31, 2023Tuesdayno time on the filingDec 31, 202210-K · Feb 13, 20239 sessions8-K
Oct 27, 2022Thursdayno time on the filingSep 30, 202210-Q · Oct 28, 20221 session8-K
Jul 28, 2022Thursdayno time on the filingJun 30, 202210-Q · Jul 29, 20221 session8-K
Apr 26, 2022Tuesdayno time on the filingMar 31, 202210-Q · Apr 28, 20222 sessions8-K
Jan 26, 2022Wednesdayno time on the filingDec 31, 202110-K · Feb 14, 202213 sessions8-K
Oct 27, 2021Wednesdayno time on the filingSep 30, 202110-Q · Oct 29, 20212 sessions8-K

The table shows the 20 most recent quarters. All 65 are in the CSV, with the same columns and one row per quarter.

Download all 65 EW quarters as CSV → Free, no account.

How Edwards Lifesciences shares moved on their latest earnings

Reported EPS beat the consensus estimate in 4 of the 5 quarters with an estimate.

AnnouncementSessionWindow, close to closeEWSPYEPS actual / expected
Jul 23, 2026no time on the filingno time: unknown which close caught it0.78 / 0.74 (+5.3%)
Apr 23, 2026no time on the filingno time: unknown which close caught it0.78 / 0.73 (+7.3%)
Feb 10, 2026no time on the filingno time: unknown which close caught it0.58 / 0.62 (−6.3%)
Oct 30, 2025no time on the filingno time: unknown which close caught it0.67 / 0.59 (+12.6%)
Jul 24, 2025no time on the filingno time: unknown which close caught it0.67 / 0.62 (+7.6%)
Apr 23, 2025no time on the filingno time: unknown which close caught it
Feb 11, 2025no time on the filingno time: unknown which close caught it
Oct 24, 2024no time on the filingno time: unknown which close caught it

Split-adjusted closes and EPS with its estimate, from Yahoo Finance. It already happened: it does not anticipate the next announcement.

Where each number comes from

From the 8-K with item 2.02 ("Results of Operations and Financial Condition") that Edwards Lifesciences filed on EDGAR, the SEC's public database; only those with their 10-Q or 10-K behind them count, so other 8-Ks with the same item (production figures, monthly sales) stay out. No time is published for this company: its EDGAR acceptance stamp and the official header of its filings disagree, so there is no way to know whether the stamp is in New York time or UTC, and the two readings are four or five hours apart —enough to change session—. The dates are firm; the time and the session are deliberately left empty rather than filled in with a guess.

What this data does not know

  • The exact time of the press release: the 8-K reaches EDGAR minutes or hours later, so any 8-K time is an upper bound. The session says which one the news landed in, not what minute it was said.
  • Nothing before Jul 21, 2010: it is Edwards Lifesciences's oldest quarter with announcement and report paired in the file.
  • What will happen. The page's only future date, Nov 4, 2026, was announced by Edwards Lifesciences on the Nasdaq calendar and can be moved.
  • Edwards Lifesciences's identity is its SEC CIK (0001099800), not its symbol: symbols get recycled and renamed.

When other Healthcare companies report earnings

More on Edwards Lifesciences

Edwards Lifesciences is in the Healthcare sector. On the model's multifactor score of Oct 21, 2026 it ranks 156 of 464, and 19 of the 55 companies in its sector that score. It is a quantitative model ranking, not a recommendation.

Edwards Lifesciences (EW) analysis page →

EW insider buys and sells →

All ~500 S&P 500 companies, sorted by when they report →

Guide: 10-K, 10-Q and 8-K · all guides

What is behind these dates

The concepts on this page, explained from scratch in the Academy. Free, no account.

The whole Academy, course by course →

Source: EDGAR, the SEC's public database (forms 8-K, 10-Q and 10-K). Data through Jul 23, 2026. This is a list of public facts and of calculations made on them, not financial advice or a recommendation to buy or sell.

The model portfolio, weekly in your inbox

Every Saturday, its week in one minute: how it went, the best and the worst, and which insiders bought with their own money. Plus, the day the model is rebuilt, which stocks come in and which go out. A simulation, not advice. At most one email a week, no ads, no account; one-click unsubscribe. Made by one person: Pol Gracia.

A model portfolio with simulated results, not a personalized recommendation. Your email is used for this only: privacy.

S&P 500 market gravity